Antibacterial Resistance Lab. Antibiotic resistance is a global public health threat estimated to risk a mortality rate of over 10 million people a year by 2050. We aim to discover new antibacterial agents and targets by understanding bacterial physiology and fundamental mechanisms of antibiotic resistance. Advanced Biomedical Research Lab. Our goal is to develop drugs to treat Hepatocellular carcinoma (HCC) and liver cirrhosis. We aim to think outside of the box by developing physiologically relevant assay systems recapitulating the tumor microenvironment and enhancing the early drug discovery pipeline converging to HCC therapeutics.